$RXMD: Progressive Care Announces New Partnership With

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
53
$RXMD: Progressive Care Announces New Partnership With MyApps, Discontinues Plans to Acquire the Company

MIAMI, FL, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that the Letter of Intent (the “LOI”) entered into on September 1, 2020, for the Company to acquire substantially all of MyApps Corp. (“MyApps”) has been terminated by the companies.

Progressive Care and MyApps will continue to work together amicably as partners, and the companies’ near-term priority will be to integrate CallingDr™, the popular telemedicine and telehealth platform developed by MyApps, into Progressive Care’s PharmcoRx digital platform and work together to enhance Progressive Care’s ClearMetrX data analytics and data management services.

“As the companies were working diligently towards an acquisition, it became increasingly clear that the parties would be better suited to be partners than to be a single organization,” said Progressive Care Chief Executive Officer Alan Jay Weisberg. “We’re extremely excited to continue our partnership to make the CallingDr™ software platform an integral part of our digital offerings.”

“Our enthusiasm about working together with Progressive Care remains unchanged,” said MyApps Founder and CEO, Adnan Malik. “After broad and intensive analysis, we collectively have concluded that we will be able to achieve more as separate entities working as allies, and we have already identified areas in which we believe we can add tangible value to Progressive Care’s offerings.”

“MyApps’ extensive and relevant experience with healthcare software development will be highly additive to our goals with ClearMetrX,” said Mr. Weisberg. “We welcome their expertise, and we remain committed as ever to exploring all meaningful ways to benefit our shareholders, employees and customers.”

For more information about Progressive Care, please visit the company’s website:

https://www.ProgressiveCareUS.com

?

Connect and stay in touch with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS
?

PharmCo Rx

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to longterm care facilities and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited statements regarding the planned partnership between the Company and MyApps, including potential integration of CallingDr™ into the PharmcoRx digital platform and working together to enhance ClearMetrX data analytics and data management services. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forwardlooking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company’s actual results, performance, prospects and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:

Carlos Rangel

carlosr@pharmcorx.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Homestyle Direct Expands Healthy Meal Delivery in Pennsylvania

Updated Category News Views 278

Homestyle Direct's Nutritional Meal Initiative Homestyle Direct is revolutionizing how eligible Medicaid members enjoy nutritious meal options. The company, based in Twin Falls, Idaho, has gained significant traction among Pennsylvania residents, particularly in areas like Erie and Allegheny counties. This initiative aligns perfectly with their commitment to providing...

Continue Reading
Elis Reports Key Shareholder Information and Voting Rights

Updated Category News Views 174

Understanding Share Capital and Voting Rights at Elis The clarity of capital structure and voting rights is crucial for investors. In the context of Elis, a prominent player in its field, this information allows stakeholders to make informed decisions regarding their investments. What is Share Capital? Share capital refers to the funds raised by a company in exchange for...

Continue Reading
Huntington Bancshares Announces Dividends for Common and Preferred Stocks

Updated Category News Views 211

Huntington Bancshares Declares Dividends for Shareholders Huntington Bancshares Incorporated has officially announced a noteworthy decision by its Board of Directors. In a recent update, the bank declared a quarterly cash dividend on its common stock, designated as Nasdaq: HBAN, maintaining its dividend at $0.155 per common share, which remains consistent with its...

Continue Reading
Grand Bay Hotel Joins Marriott Family for Enhanced Guest Experience

Updated Category News Views 385

Grand Bay Hotel Embraces Marriott Affiliation The Grand Bay Hotel San Francisco has embarked on an exciting new journey as it officially becomes part of the Marriott hotel portfolio, opening the door to a wealth of global opportunities and unique benefits for its guests. This strategic affiliation promises to enhance the overall guest experience, from the luxurious...

Continue Reading
Strategic Alliance to Transform China's Auto Parts Sector

Updated Category News Views 194

Autozi Internet Technology's New Partnership Autozi Internet Technology (Global) Ltd. (NASDAQ: AZI) is making waves in the auto parts industry with its latest strategic partnership. This collaboration with the China Auto Maintenance Parts Alliance signifies a major move towards digitizing the auto parts market. On a recent day, Autozi's stock experienced an impressive...

Continue Reading